Approval · Notice of Compliance 30141 · 2023
FROVATRIPTAN: Notice of Compliance 30141
Issued February 16, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30141
- Date
- February 16, 2023
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement Between Two Companies
- Canadian reference product
- FROVA (Endo Pharmaceuticals Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FROVATRIPTAN | 02535475 | Marketed |
Medicinal ingredients
- FROVATRIPTAN SUCCINATE 2.5 MG per TAB